MedPath

Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFD

Phase 2
Conditions
Intrauterine fetal death.
Complications following (induced) termination of pregnancy
Registration Number
IRCT20181218042033N2
Lead Sponsor
Bandare-abbas University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
106
Inclusion Criteria

Pregnant women with 18 to 40 years of age confirmed by IUFD
gestational age of 15 to 26 weeks

Exclusion Criteria

Multiparty more than 6
Coagulopathy
Multi fetal pregnancy
Any obstacle to induction of labor (e.g. maternal heart disease, clinical chorioamnionitis, vasa previa, placenta previa, invasive cervical carcinoma, myoma surgery or any surgery that has cut the uterine)
Having one or more caesarean section
History of any uterine incision (myomectomy and etc.).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Induction- to-delivery interval time. Timepoint: 6-48 hours after misoprostol and oxytocin administration. Method of measurement: clock.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath